NEW YORK, NY — As the world enters the second week of Breast Cancer Awareness Month, a global movement is preparing to shift the spotlight toward a often-overlooked reality of the disease. On October 13, 2026, National Metastatic Breast Cancer Awareness Day, more than 325 iconic landmarks across the globe will be bathed in teal, green, and pink. This coordinated display, orchestrated by the #LightUpMBC campaign in partnership with METAvivor Research and Support, aims to bring visibility to metastatic breast cancer (MBC)—the only form of breast cancer that kills.
While the "pink ribbon" culture of October often focuses on early detection and the celebration of "survivorship" following successful treatment, the #LightUpMBC campaign seeks to highlight the 30% of breast cancer patients who will eventually see their disease progress to Stage 4, for which there is currently no cure.
Main Facts: A Global Beacon for the Metastatic Community
The 2026 #LightUpMBC campaign represents the largest coordinated awareness effort in the history of the metastatic community. Spanning all 50 U.S. states, 20 countries, and 195 cities, the initiative uses the visual power of light to demand attention for a disease that claims approximately 42,670 lives annually in the United States alone.
The Significance of the Colors
Unlike the traditional monochromatic pink associated with general breast cancer awareness, the #LightUpMBC campaign utilizes a specific tri-color palette:
- Teal: Representing the original site of the cancer (the breast) and the spirit of healing.
- Green: Symbolizing the hope of renewal and the "green light" for more research and life-extending treatments.
- Pink: Acknowledging the origins of the disease while distinguishing the unique needs of the metastatic community.
The Centerpiece Event
The culmination of the day’s activities is #LightUpMBC Live, a free virtual broadcast scheduled for 8:00 p.m. ET (5:00 p.m. PT). The program is designed to bridge the gap between the scientific community and the patient population. Hosted by Tami Eagle Bowling, a prominent advocate living with MBC for 11 years, and Broadway star Kara Lindsay, the event will feature a blend of personal testimonials, musical performances from Tony Award winners, and updates on the latest clinical research funded by METAvivor.
Chronology: From a Single Bridge to a Global Network
The evolution of #LightUpMBC is a testament to the power of grassroots advocacy and the legacy of those lost to the disease.
The Inspiration (2017)
The campaign traces its roots back to Jessica Moore, a young woman diagnosed with MBC who recognized the disparity in how Stage 4 patients were represented in mainstream awareness campaigns. Jessica’s simple hope was to see a single local landmark illuminated in the MBC colors to validate the experiences of those living with terminal diagnoses. In 2017, the Memorial Bridge in Portsmouth, New Hampshire, became the first landmark to light up for the cause.
Expansion and Formalization
Following Jessica’s passing at the age of 36, her best friend, Laura Inahara, founded #LightUpMBC to fulfill and expand upon Jessica’s vision. What began as a local tribute quickly resonated with patients and families worldwide who felt "pink-washed" by traditional October messaging.
- 2017–2020: The campaign grew from a handful of bridges in New England to dozens of landmarks across the Northeast.
- 2021–2025: Strategic partnerships with METAvivor allowed the campaign to go national and then international, securing participation from major architectural icons like One World Trade Center and Niagara Falls.
- 2026: The current campaign marks a record-breaking year with over 325 landmarks, including the Mactan-Cebu Airport in the Philippines and Ness Bridge in Scotland, signaling the truly global nature of the MBC crisis.
To date, the campaign has raised over $2.7 million, with 100% of net proceeds directed toward scientific research grants specifically for Stage 4 breast cancer.
Supporting Data: The Sobering Reality of Stage 4
The necessity of the #LightUpMBC campaign is underscored by epidemiological data and funding statistics that reveal a significant gap in the oncology landscape.
Mortality and Prevalence
Metastatic breast cancer occurs when cancer cells break away from the original tumor in the breast and travel through the lymphatic system or bloodstream to distant organs, most commonly the bones, liver, lungs, or brain.
- Daily Toll: In 2026, it is estimated that 117 people in the U.S. die from MBC every single day.
- Diagnosis Timing: While many are diagnosed after a recurrence of an earlier-stage cancer, a significant percentage of patients are "de novo," meaning they are diagnosed at Stage 4 from their very first screening.
- The "Cure" Fallacy: For those with MBC, treatment is a lifelong requirement. Even when a patient reaches a state of "No Evidence of Disease" (NED), the cancer remains present at a cellular level, often developing resistance to current therapies over time.
The Research Funding Gap
Historically, only a small fraction of overall breast cancer research funding (often estimated at less than 7% globally) is dedicated to researching metastatic disease. Most funding is channeled toward early detection and prevention. While these are critical areas, they offer little hope to the hundreds of thousands of people already living with Stage 4 disease. METAvivor remains one of the few organizations that exclusively funds research for those already in the metastatic stage.
Official Responses: Voices of Advocacy and Science
The leadership of METAvivor and the creators of #LightUpMBC emphasize that while the lights are beautiful, the underlying mission is urgent and scientific.
Dr. Kelly Shanahan, METAvivor Board President, who has lived with MBC since 2013, highlighted the personal stakes of the campaign:
"When I was diagnosed 13 years ago, the statistics suggested I wouldn’t be here today. My survival is not a miracle; it is the result of scientific advancement. However, we are still losing over 40,000 people a year. #LightUpMBC is the biggest contributor to the research we fund, and it serves as a vital beacon of community for those of us who often feel invisible during Breast Cancer Awareness Month."
Laura Inahara, Founder of #LightUpMBC, spoke to the emotional resonance of the 2026 event:
"Jessica Moore’s legacy is now shining in 20 countries. This isn’t just about pretty lights; it’s about teaching patients how to advocate for their lives and ensuring that the next generation of patients has more than just a few years of survival. We have raised $2.7 million, but we need more to turn this terminal disease into a chronic, manageable one."
Tami Eagle Bowling, Campaign Director and #LightUpMBC Live Host, emphasized the educational aspect of the broadcast:
"The live stream allows us to put faces and stories to the statistics. When people see Broadway stars performing alongside scientists who are developing the next breakthrough drug, it creates a sense of momentum. We are moving the needle from awareness to action."
Implications: Changing the Future of Oncology
The #LightUpMBC campaign has implications that reach far beyond a single night of illumination. It represents a paradigm shift in how society views and treats terminal illness.
Shifting the Narrative
By emphasizing teal and green alongside pink, the campaign is successfully diversifying the "Breast Cancer Awareness" brand. This shift encourages donors to ask where their money is going, leading to a more informed public that understands the difference between screening (prevention) and metastatic research (survival).
The Goal of Survivability
The ultimate aim of METAvivor-funded research is to transform MBC from a terminal diagnosis into a survivable, chronic condition—similar to how HIV/AIDS was transformed in the 1990s. By funding projects through a rigorous peer-review process that includes both scientists and patient advocates, METAvivor ensures that the research being conducted is directly aligned with the quality-of-life needs of the patients.
Global Solidarity and Advocacy
As landmarks like the Willis Tower in Chicago and the Philadelphia City Hall join international sites, the movement creates a "global classroom." The participation of 195 cities provides a platform for local advocates to engage with their municipal governments, often leading to official proclamations and increased local support for MBC patients.
How to Participate
The public is encouraged to engage with the campaign by:
- Photography: Taking photos of participating landmarks on October 13 and sharing them on social media using the hashtags #LightUpMBC and #METAvivor.
- Education: Tuning into the #LightUpMBC Live broadcast at 8 p.m. ET via YouTube, Facebook, or LiveOne to hear from experts and survivors.
- Contribution: Donating through the official website, where 100% of net proceeds are dedicated to Stage 4 research.
As October 13 approaches, the metastatic community prepares to step out of the shadows. For one night, the world will not just be pink; it will be a vibrant testament to the resilience of those living with Stage 4 cancer and a collective call for the research that will one day save their lives.
About METAvivor:
METAvivor Research and Support Inc. is a 501(c)(3) nonprofit organization dedicated to the specific fight against Stage 4 metastatic breast cancer. At the heart of their mission is a commitment to transparency and scientific excellence, ensuring that every dollar raised for research goes toward projects that have the potential to extend and improve the lives of MBC patients. For more information, visit www.metavivor.org.
About the Author
